glp 1 medi cal coverage BREAKING: Medi-Cal Ends for Ozempic, Wegovy, Mounjaro & All GLP-1 Weight-Loss Drugs Jan 1, 2026, Sacramento, CA (Nov 2, 2025), California’s Medi-Cal will stop covering GLP-1 drugs (Ozempic, California's Proposal to Cut GLP-1

BPC-157 is a peptide that is naturally occurring in the human body and has been studied for its potential therapeutic effects on the body, particularly in the healing of injuries and digestive tract disorders

Animal studies have found that coenzyme Q10 helps the immune system work better and makes the body better able to resist certain infections and types of cancer

Epitalon: Linked to longevity and telomere support

Scalp Environment: It supports circulation and manages the inflammatory response

Chromium picolinate is sometimes marketed for blood sugar support, though evidence for direct effects on GLP-1 or GIP is minimal

This endogenous production represents the primary way nutrition affects your GLP-1 levels